Charity BreakdownCanadian charity filings, itemized

JDRF Canadian Clinical Trial Network

Charitable organization · North York, Ontario · BN 812584068RR0001 · Research

Your $100, itemizedJDRF Canadian Clinical Trial NetworkFiscal year ended December 31, 2024
Gifts to other charities$70
Management & admin$14
Charitable programs$11
Fundraising$5
TOTAL$100
Registered

Source: T3010 return, FPE 2024-12-31. Split of total expenditures ($320,372) as filed with the CRA.

JDRF Canadian Clinical Trial Network is a charitable organization based in North York, Ontario, classified by the CRA under research. In its fiscal year ending December 31, 2024, it reported $105K in revenue and $320K in expenditures. Spending exceeded revenue that year — the gap came out of reserves.

Its funding that year was roughly 61% from other charities. In 2024, 16 other registered charities reported granting it a combined $174K.

Compared with 1,764 education charities of similar size, its share of spending on mission — charitable programs plus grants to other charities — ranked above 46% of peers.

It reported gifts to 1 qualified donee totalling $225K in 2024, the largest being $225K to The University of British Columbia. Revenue has declined over its filings on record here, from $249K in 2020 to $105K in 2024. Its filed list of directors and trustees shows 6 names.

In its own words

Cctn creates a strong clinical research network to develop and conduct leading-edge clinical trials into type 1 diabetes and its complications in order to accelerate delivery of the benefits of research advances to the community.

Ongoing-program description from its T3010 filing, verbatim.

The ledger, 20202024

YearRevenueSpendingProgramsFundraisingGifts outNet assets
2024$105K$320K$34K$17K$225K$0
2023$130K$730K$30K$25K$625K$0
2022$199K$449K$94K$41K$250K$0
2021$300K$525K$95K$49K$317K$0
2020$249K$331K$97K$27K$140K$0

Revenue printed in red where the year ran a deficit. Fiscal years by period end.

Money between charities, 2024

As reported on the donors’ own T3010 qualified-donee schedules.

Directors & trustees (2024)

Aubrey Baillie (chair of the board); Alex Davidson (treasurer); Sheldon Finkelstein (board member); Nick Hajidiacos (board member); Lorne Shiff (board member); Jessica Diniz (director).

As listed on its 2024 return.

Check the source

Every figure on this page is from JDRF Canadian Clinical Trial Network’s own T3010 filings, published by the Canada Revenue Agency. Verify against the CRA’s charities listing (search BN 812584068RR0001), or read how we compute the receipt.